Curie.Bio
Kelly Moynihan is an experienced professional in the biotechnology sector, currently serving as the VP of the CSO Partner Team at Curie.Bio since January 2025. Previously, Kelly was involved in building a seed-stage new company from January to December 2024 and held various leadership roles at Asher Biotherapeutics from January 2020 to December 2024, including Senior Director and Project Team Leader. Prior experience includes positions at Third Rock Ventures as a Senior Associate and Associate from January 2017 to December 2020 and a consulting role at Elicio Therapeutics in 2017. Kelly holds a Doctor of Philosophy in Biological Engineering from the Massachusetts Institute of Technology and a Bachelor of Science in Biomedical Engineering from the University of Texas at Austin.
This person is not in any teams
This person is not in any offices